{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T04:57:57Z","timestamp":1773809877950,"version":"3.50.1"},"reference-count":39,"publisher":"Japan Atherosclerosis Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT"],"published-print":{"date-parts":[[2014]]},"DOI":"10.5551\/jat.20594","type":"journal-article","created":{"date-parts":[[2013,12,9]],"date-time":"2013-12-09T22:59:27Z","timestamp":1386629967000},"page":"346-354","source":"Crossref","is-referenced-by-count":22,"title":["Kidney Function, Cholesterol Absorption and Remnant Lipoprotein Accumulation in Patients with Diabetes Mellitus"],"prefix":"10.5551","volume":"21","author":[{"given":"Mika","family":"Sonoda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Testuo","family":"Shoji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Kimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujiro","family":"Okute","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Shima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihide","family":"Naganuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koka","family":"Motoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoaki","family":"Morioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuhito","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Fukumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Shioi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenori","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Emoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Inaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Kugiyama K, Doi H, Takazoe K, Kawano H, Soejima H, Mizuno Y, Tsunoda R, Sakamoto T, Nakano T, Nakajima K, Ogawa H, Sugiyama S, Yoshimura M, Yasue H: Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease. Circulation, 1999; 99: 2858-2860","DOI":"10.1161\/01.CIR.99.22.2858"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Fujioka Y, Ishikawa Y: Remnant lipoproteins as strong key particles to atherogenesis. J Atheroscler Thromb, 2009; 16: 145-154","DOI":"10.5551\/jat.E598"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis, 1998; 32: S112-119","DOI":"10.1053\/ajkd.1998.v32.pm9820470"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Ninomiya T, Kiyohara Y, Tokuda Y, Doi Y, Arima H, Harada A, Ohashi Y, Ueshima H, Japan Arteriosclerosis Longitudinal Study G: Impact of kidney disease and blood pressure on the development of cardiovascular disease: an overview from the Japan Arteriosclerosis Longitudinal Study. Circulation, 2008; 118: 2694-2701","DOI":"10.1161\/CIRCULATIONAHA.108.792903"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Nestel PJ, Fidge NH, Tan MH: Increased lipoproteinremnant formation in chronic renal failure. N Engl J Med, 1982; 307: 329-333","DOI":"10.1056\/NEJM198208053070601"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Shoji T, Nishizawa Y, Kawagishi T, Tanaka M, Kawasaki K, Tabata T, Inoue T, Morii H: Atherogenic lipoprotein changes in the absence of hyperlipidemia in patients with chronic renal failure treated by hemodialysis. Atherosclerosis, 1997; 131: 229-236","DOI":"10.1016\/S0021-9150(97)00054-3"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Oda H, Yorioka N, Okushin S, Nishida Y, Kushihata S, Ito T, Yamakido M: Remnant-like particle cholesterol may indicate atherogenic risk in patients on chronic hemodialysis. Nephron, 1997; 76: 7-14","DOI":"10.1159\/000190133"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Hirany S, O\u2019Byrne D, Devaraj S, Jialal I: Remnant-like particle-cholesterol concentrations in patients with type 2 diabetes mellitus and end-stage renal disease. Clin Chem, 2000; 46: 667-672","DOI":"10.1093\/clinchem\/46.5.667"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Kimoto E, Shoji T, Emoto M, Miki T, Tabata T, Okuno Y, Ishimura E, Inaba M, Nishizawa Y: Effect of diabetes on uremic dyslipidemia. J Atheroscler Thromb, 2002; 9: 305-313","DOI":"10.5551\/jat.9.305"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Hayashi T, Hirano T, Taira T, Tokuno A, Mori Y, Koba S, Adachi M: Remarkable increase of apolipoprotein B48 level in diabetic patients with end-stage renal disease. Atherosclerosis, 2008; 197: 154-158","DOI":"10.1016\/j.atherosclerosis.2007.03.015"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Homma K, Homma Y, Yamaguchi S, Shiina Y, Wakino S, Hayashi K, Hori S, Itoh H: Triglyceride-rich lipoproteins in chronic kidney disease patients undergoing maintenance haemodialysis treatment. Int J Clin Pract, 2012; 66: 394-398","DOI":"10.1111\/j.1742-1241.2011.02862.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Shoji T, Nishizawa Y, Kawagishi T, Kawasaki K, Taniwaki H, Tabata T, Inoue T, Morii H: Intermediate-density lipoprotein as an independent risk factor for aortic atherosclerosis in hemodialysis patients. J Am Soc Nephrol, 1998; 9: 1277-1284","DOI":"10.1681\/ASN.V971277"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Shoji T, Emoto M, Shinohara K, Kakiya R, Tsujimoto Y, Kishimoto H, Ishimura E, Tabata T, Nishizawa Y: Diabetes mellitus, aortic stiffness, and cardiovascular mortality in end-stage renal disease. J Am Soc Nephrol, 2001; 12: 2117-2124","DOI":"10.1681\/ASN.V12102117"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Nozue T, Michishita I, Ito Y, Hirano T: Effects of statin on small dense low-density lipoprotein cholesterol and remnant-like particle cholesterol in heterozygous familial hypercholesterolemia. J Atheroscler Thromb, 2008; 15: 146-153","DOI":"10.5551\/jat.E552"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Nozue T, Michishita I, Mizuguchi I: Effects of ezetimibe on remnant-like particle cholesterol, lipoprotein (a), and oxidized low-density lipoprotein in patients with dyslipidemia. J Atheroscler Thromb, 2010; 17: 37-44","DOI":"10.5551\/jat.1651"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Buchwald H, Varco RL, Matts JP, Long JM, Fitch LL, Campbell GS, Pearce MB, Yellin AE, Edmiston WA, Smink RD Jr, et al: Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias(POSCH). N Engl J Med, 1990; 323: 946-955","DOI":"10.1056\/NEJM199010043231404"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Strandberg TE, Tilvis RS, Pitkala KH, Miettinen TA: Cholesterol and glucose metabolism and recurrent cardiovascular events among the elderly: a prospective study. J Am Coll Cardiol, 2006; 48: 708-714","DOI":"10.1016\/j.jacc.2006.04.081"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Miettinen TA, Gylling H: Cholesterol absorption efficiency and sterol metabolism in obesity. Atherosclerosis, 2000; 153: 241-248","DOI":"10.1016\/S0021-9150(00)00404-4"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Lally SE, Owens D, Tomkin GH: Sitosterol and cholesterol in chylomicrons of type 2 diabetic and non-diabetic subjects: the relationship with ATP binding cassette proteins G5 and G8 and Niemann-Pick C1-like 1 mRNA. Diabetologia, 2007; 50: 217-219","DOI":"10.1007\/s00125-006-0504-0"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Fukushima M, Miura S, Mitsutake R, Fukushima T, Fukushima K, Saku K: Cholesterol metabolism in patients with hemodialysis in the presence or absence of coronary artery disease. Circ J, 2012; 76: 1980-1986","DOI":"10.1253\/circj.CJ-11-1302"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Miyauchi K, Kayahara N, Ishigami M, Kuwata H, Mori H, Sugiuchi H, Irie T, Tanaka A, Yamashita S, Yamamura T: Development of a homogeneous assay to measure remnant lipoprotein cholesterol. Clin Chem, 2007; 53: 2128-2135","DOI":"10.1373\/clinchem.2007.092296"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A: Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis, 2009; 53: 982-992","DOI":"10.1053\/j.ajkd.2008.12.034"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Siirtola A, Ketomaki A, Miettinen TA, Gylling H, Lehtimaki T, Holmberg C, Salo MK, Antikainen M: Cholesterol absorption and synthesis in pediatric kidney, liver, and heart transplant recipients. Transplantation, 2006; 81: 327-334","DOI":"10.1097\/01.tp.0000189173.46727.18"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Rogacev KS, Pinsdorf T, Weingartner O, Gerhart MK, Welzel E, van Bentum K, Popp J, Menzner A, Fliser D, Lutjohann D, Heine GH: Cholesterol synthesis, cholesterol absorption, and mortality in hemodialysis patients. Clin J Am Soc Nephrol, 2012; 7: 943-948","DOI":"10.2215\/CJN.05170511"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) de Vogel-van den Bosch HM, Bunger M, de Groot PJ, Bosch-Vermeulen H, Hooiveld GJ, Muller M: PPARalpha-mediated effects of dietary lipids on intestinal barrier gene expression. BMC Genomics, 2008; 9: 231","DOI":"10.1186\/1471-2164-9-231"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Mori Y, Hirano T, Nagashima M, Shiraishi Y, Fukui T, Adachi M: Decreased peroxisome proliferator-activated receptor alpha gene expression is associated with dyslipidemia in a rat model of chronic renal failure. Metabolism, 2007; 56: 1714-1718","DOI":"10.1016\/j.metabol.2007.07.016"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Shoji T, Kakiya R, Hayashi T, Tsujimoto Y, Sonoda M, Shima H, Mori K, Fukumoto S, Tahara H, Shioi A, Tabata T, Emoto M, Nishizawa Y, Inaba M: Serum n-3 and n-6 Polyunsaturated Fatty Acid Profile as an Independent Predictor of Cardiovascular Events in Hemodialysis Patients. Am J Kidney Dis, 2013; 62: 568-576","DOI":"10.1053\/j.ajkd.2013.02.362"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Tsuchikura S, Shoji T, Shimomura N, Kakiya R, Emoto M, Koyama H, Ishimura E, Inaba M, Nishizawa Y: Serum C-reactive protein and thioredoxin levels in subjects with mildly reduced glomerular filtration rate. BMC Nephrol, 2010; 11: 7","DOI":"10.1186\/1471-2369-11-7"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Fouque D, Kalantar-Zadeh K, Kopple J, Cano N, Chauveau P, Cuppari L, Franch H, Guarnieri G, Ikizler TA, Kaysen G, Lindholm B, Massy Z, Mitch W, Pineda E, Stenvinkel P, Trevino-Becerra A, Wanner C: A proposed nomenclature and diagnostic criteria for proteinenergy wasting in acute and chronic kidney disease. Kidney Int, 2008; 73: 391-398","DOI":"10.1038\/sj.ki.5002585"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Shoji T, Nishizawa Y, Nishitani H, Yamakawa M, Morii H: Roles of hypoalbuminemia and lipoprotein lipase on hyperlipoproteinemia in continuous ambulatory peritoneal dialysis. Metabolism, 1991; 40: 1002-1008","DOI":"10.1016\/0026-0495(91)90120-L"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Shoji T, Emoto M, Kawagishi T, Kimoto E, Yamada A, Tabata T, Ishimura E, Inaba M, Okuno Y, Nishizawa Y: Atherogenic lipoprotein changes in diabetic nephropathy. Atherosclerosis, 2001; 156: 425-433","DOI":"10.1016\/S0021-9150(00)00673-0"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Sato I, Ishikawa Y, Ishimoto A, Katsura S, Toyokawa A, Hayashi F, Kawano S, Fujioka Y, Yamashita S, Kumagai S: Significance of measuring serum concentrations of remnant lipoproteins and apolipoprotein B-48 in fasting period. J Atheroscler Thromb, 2009; 16: 12-20","DOI":"10.5551\/jat.E596"},{"key":"33","unstructured":"33) Nagashima M, Mori Y, Morita R, Takada M, Lee S, Taira T, Miyauchi K, Kuwata H, Kayahara N, Hirano T: Remnant lipoprotein cholesterol homogenous assay(RemL-C) is closely associated with very-low-density lipoprotein remnants: comparison with the immunoseparation assay. Rinsho Byori, 2008; 56: 973-979"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Yoshida H, Kurosawa H, Hirowatari Y, Ogura Y, Ikewaki K, Abe I, Saikawa S, Domitsu K, Ito K, Yanai H, Tada N: Characteristic comparison of triglyceride-rich remnant lipoprotein measurement between a new homogenous assay(RemL-C) and a conventional immunoseparation method(RLP-C). Lipids Health Dis, 2008; 7: 18","DOI":"10.1186\/1476-511X-7-18"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Shoji T, Abe T, Matsuo H, Egusa G, Yamasaki Y, Kashihara N, Shirai K, Kashiwagi A, Committee of R, Peripheral Arteries JAS: Chronic kidney disease, dyslipidemia, and atherosclerosis. J Atheroscler Thromb, 2012; 19: 299-315","DOI":"10.5551\/jat.10454"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Keane WF, Tomassini JE, Neff DR: Lipid abnormalities in patients with chronic kidney disease: implications for the pathophysiology of atherosclerosis. J Atheroscler Thromb, 2013; 20: 123-133","DOI":"10.5551\/jat.12849"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Ikewaki K, Schaefer JR, Frischmann ME, Okubo K, Hosoya T, Mochizuki S, Dieplinger B, Trenkwalder E, Schweer H, Kronenberg F, Koenig P, Dieplinger H: Delayed in vivo catabolism of intermediate-density lipoprotein and low-density lipoprotein in hemodialysis patients as potential cause of premature atherosclerosis. Arterioscler Thromb Vasc Biol, 2005; 25: 2615-2622","DOI":"10.1161\/01.ATV.0000188555.60475.c2"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Mordasini R, Frey F, Flury W, Klose G, Greten H: Selective deficiency of hepatic triglyceride lipase in uremic patients. N Engl J Med, 1977; 297: 1362-1366","DOI":"10.1056\/NEJM197712222972502"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Shoji T, Nishizawa Y, Nishitani H, Yamakawa M, Morii H: Impaired metabolism of high density lipoprotein in uremic patients. Kidney Int, 1992; 41: 1653-1661","DOI":"10.1038\/ki.1992.238"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,3,19]],"date-time":"2022-03-19T10:59:15Z","timestamp":1647687555000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/21\/4\/21_20594\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.20594","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}